Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Retinylamine derivitives for treatment of ocular disorders

Retinylamine derivitives for treatment of ocular disorders

US Patent 11793853 · Granted Oct 24, 2023

Estimated economic value: $255,190,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for the delivery of nucleic acids2025
Compounds and methods of treating retinal degeneration2025
Compositions and methods for the delivery of nucleic acids2024
Visual cycle modulators2024
Compositions and methods for the delivery of nucleic acids2024
Arctigenin liquid nano-preparation and preparation method thereof2024
Compounds and methods of treating retinal degeneration2023
Molecular probes and methods of use2023
Compositions and methods for the delivery of nucleic acids2022
Visual cycle modulators2022
Compounds and methods of treating retinal degeneration2021
Compositions and methods for the delivery of nucleic acids2021